Resveratrol
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
226 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 4 | 3 | 1 | 1 | 7 | 16 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | 5 | 2 | 2 | 7 | 15 |
| Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 1 | 1 | — | 1 | 1 | 4 |
| Allergic rhinitis | D065631 | — | J30.9 | — | — | 1 | 1 | — | 2 |
| Rhinitis | D012220 | EFO_0008521 | J31 | — | — | 1 | 1 | — | 2 |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | — | — | — | 1 | — | 1 |
| Endometriosis | D004715 | EFO_0001065 | N80 | — | — | — | 1 | — | 1 |
| Gestational diabetes | D016640 | — | O24.4 | — | — | — | 1 | — | 1 |
| Pancreatitis | D010195 | EFO_0000278 | K85 | — | — | — | 1 | — | 1 |
| Gastrointestinal diseases | D005767 | — | — | — | — | — | 1 | — | 1 |
Show 3 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | — | 1 | 3 | — | 12 | 16 |
| Healthy volunteers/patients | — | — | — | 3 | 1 | 1 | — | 10 | 15 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 2 | 3 | 2 | — | 8 | 14 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 3 | 1 | — | 5 | 8 |
| Overweight | D050177 | — | E66.3 | — | 1 | 1 | — | 6 | 7 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 2 | 2 | 2 | — | — | 6 |
| Cognitive dysfunction | D060825 | — | G31.84 | 2 | 2 | 2 | — | — | 5 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 2 | 2 | — | 2 | 4 |
| Fatty liver | D005234 | EFO_0003934 | — | — | 2 | 2 | — | 2 | 4 |
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | 1 | 1 | — | 1 | 4 |
Show 23 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | — | 14 | 15 |
| Syndrome | D013577 | — | — | 1 | 1 | — | — | 8 | 10 |
| Aging | D000375 | GO_0007568 | R41.81 | 1 | 1 | — | — | 5 | 7 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | 2 | — | — | 3 | 5 |
| Covid-19 | D000086382 | — | U07.1 | — | 2 | — | — | 2 | 4 |
| Glucose intolerance | D018149 | HP_0000833 | R73.03 | 1 | 1 | — | — | 2 | 3 |
| Hypertension | D006973 | EFO_0000537 | I10 | 2 | 1 | — | — | 1 | 3 |
| Macular degeneration | D008268 | EFO_0001365 | H35.30 | — | 1 | — | — | 2 | 3 |
| Muscle spasticity | D009128 | — | — | — | 1 | — | — | 1 | 2 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | — | 1 | — | — | 1 | 2 |
Show 28 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Parkinson disease | D010300 | EFO_0002508 | G20 | 7 | — | — | — | — | 7 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | 1 | — | — | — | 4 | 5 |
| Disease | D004194 | EFO_0000408 | R69 | 2 | — | — | — | 1 | 3 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | 2 | 3 |
| Lung diseases | D008171 | EFO_0003818 | J98.4 | 1 | — | — | — | 2 | 3 |
| Obstructive lung diseases | D008173 | — | — | 1 | — | — | — | 2 | 3 |
| Oxidative stress | D018384 | EFO_1001905 | — | 1 | — | — | — | 2 | 3 |
| Colonic neoplasms | D003110 | — | C18 | 3 | — | — | — | — | 3 |
| Memory disorders | D008569 | — | — | 1 | — | — | — | 1 | 2 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | 1 | — | — | — | 1 | 2 |
Show 19 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Coronary artery disease | D003324 | — | I25.1 | — | — | — | — | 5 | 5 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | — | 3 | 3 |
| Diabetic retinopathy | D003930 | EFO_0003770 | — | — | — | — | — | 2 | 2 |
| Affect | D000339 | — | — | — | — | — | — | 2 | 2 |
| Weight loss | D015431 | — | — | — | — | — | — | 2 | 2 |
| Coronary disease | D003327 | — | — | — | — | — | — | 2 | 2 |
| Respiratory tract infections | D012141 | — | J06.9 | — | — | — | — | 2 | 2 |
| Respiratory sounds | D012135 | — | R06.1 | — | — | — | — | 2 | 2 |
| Hypoxia | D000860 | — | R09.02 | — | — | — | — | 2 | 2 |
| Eye diseases | D005128 | EFO_0003966 | H44 | — | — | — | — | 2 | 2 |
Show 87 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
25 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use